Gencurix Inc. (KOSDAQ:229000)
South Korea · Delayed Price · Currency is KRW 1,488.00
-7.00 (-0.47%)
Oct 31, 2025, 3:30 PM KST
Gencurix Market Cap
Gencurix has a market cap or net worth of 23.98 billion as of October 31, 2025. Its market cap has decreased by -41.51% in one year.
Market Cap
23.98B
Enterprise Value
26.59B
Revenue
3.39B
Ranking
n/a
PE Ratio
n/a
Stock Price
1,488.00
Market Cap Chart
Since April 5, 2017, Gencurix's market cap has decreased from 73.36B to 23.98B, a decrease of -67.31%. That is a compound annual growth rate of -12.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2025 | 24.10B | -19.76% |
| Dec 30, 2024 | 30.03B | -64.40% |
| Dec 28, 2023 | 84.35B | 82.80% |
| Dec 29, 2022 | 46.15B | -60.69% |
| Dec 30, 2021 | 117.40B | 11.19% |
| Dec 30, 2020 | 105.58B | 18.66% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 87.69T |
| Celltrion | 39.50T |
| ALTEOGEN | 25.46T |
| SK Biopharmaceuticals | 8.97T |
| Yuhan | 8.77T |
| HLB Co., Ltd. | 6.25T |
| Peptron | 6.18T |
| PharmaResearch | 5.57T |